Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s11427-016-5023-8
Published Online: 2016-03-11
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Kaichao
Guo, Yelei
Dai, Hanren
Wang, Yao
Li, Xiang
Jia, Hejin
Han, Weidong